| Period Ending | Mar 30, 2010 | Mar 30, 2009 | Mar 30, 2008 | Mar 30, 2007 |
|---|
|
Total Revenue
|
925,193,000
|
708,810,000
|
356,601,000
|
323,612,000
| | Cost of Revenue | 599,525,000 | 456,525,000 | 272,470,000 | 258,967,000 | | |
Gross Profit
|
325,668,000
|
252,284,000
|
84,130,000
|
64,645,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 877,470,000 | 711,904,000 | 322,552,000 | 290,856,000 | | | |
Operating Income or Loss
|
47,722,000
|
(3,094,000)
|
34,049,000
|
32,756,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 47,722,000 | (3,094,000) | 34,049,000 | 32,756,000 |
|
Interest Expense | (17,940,000) | (16,905,000) | (6,425,000) | (4,864,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 10,058,000 | 3,358,000 | 8,515,000 | 8,832,000 |
|
Minority Interest | (303,000) | 115,000 | (1,323,000) | (742,000) |
|
|
|
Net Income From Continuing Ops | 25,711,000 | (25,053,000) | 21,677,000 | 21,700,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
25,711,000
|
(25,053,000)
|
21,677,000
|
21,973,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|